These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38023961)

  • 1. Adverse events following immunization (AEFI): COVID-19 vaccine dose and characteristics in Central Java, Indonesia.
    Wahyudi F; Nugraheni A; Margawati A; Pramono D; Adespin DA; Nugroho TW; Pramana C
    Germs; 2023 Mar; 13(1):40-49. PubMed ID: 38023961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events following immunization of COVID-19 vaccine among children aged 6-11 years.
    Puspitarani F; Sitaresmi MN; Ahmad RA
    Front Public Health; 2022; 10():999354. PubMed ID: 36388348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Vaccines Programs: adverse events following immunization (AEFI) among medical Clerkship Student in Jember, Indonesia.
    Supangat ; Sakinah EN; Nugraha MY; Qodar TS; Mulyono BW; Tohari AI
    BMC Pharmacol Toxicol; 2021 Oct; 22(1):58. PubMed ID: 34641944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of Adverse Events Following Immunization (AEFI) after Third Dose Booster Vaccination with mRNA-Based Vaccine in Universitas Indonesia Hospital Health Personnel.
    Hidayat R; Mustika AP; Avisha F; Djuliannisaa Z; Winari DD; Putri RA; Lisman HM; Davin V; Widhani A; Aini MH; Rahmadani M; Istanti ND; Giantini A
    Vaccines (Basel); 2022 May; 10(6):. PubMed ID: 35746485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand.
    Mahasing C; Doungngern P; Jaipong R; Nonmuti P; Chimmanee J; Wongsawat J; Boonyasirinant T; Wanlapakorn C; Leelapatana P; Yingchoncharoen T; Ngarmukos T; Chokephaibulkit K; Srimahachota S
    Vaccines (Basel); 2023 Mar; 11(4):. PubMed ID: 37112661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events following the first dose of Covishield (ChAdOx1 nCoV-19) vaccination among health workers in selected districts of central and western Nepal: A cross-sectional study.
    Subedi P; Yadav GK; Paudel B; Regmi A; Pyakurel P
    PLoS One; 2021; 16(12):e0260638. PubMed ID: 34932553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal.
    Rayamajhi S; Rafi MA; Tripathi N; Dongol AS; Pandey M; Rayamajhi S; Bhandari S; Shrestha P; Hasan MT; Hossain MG
    PLoS One; 2022; 17(8):e0272729. PubMed ID: 35947626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Adverse Effects of COVID-19 Vaccines Experienced by Healthcare Workers at Guizhou Provincial Staff Hospital, China.
    Wei Y; Wang Y; Liu L; Zha Y; Yang Y; Wang Y; Roberts N; Li Y
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cross-Sectional Study to Assess mRNA-COVID-19 Vaccine Safety among Indian Children (5-17 Years) Living in Saudi Arabia.
    Ahsan M; Shaik RA; Mallick AK; Banawas SS; Alruwaili TAM; Alanazi YA; Alzahrani HS; Ahmad RK; Ahmad MS; AlAnazi FH; Alfhaid F; Aljulifi MZ; Mehta V; Almhmd AE; Daham ASDA; Alruwaili MMM
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Adverse Events Experienced by Healthcare Workers following Immunization with Homologous orHeterologous COVID-19 Booster Vaccinations.
    Wei Y; Wang Y; Liu J; Zha Y; Yang Y; Li N; Zhou Y; Roberts JZN; Liu L; Li Y
    Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36366377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021.
    Tran VN; Nguyen HA; Le TTA; Truong TT; Nguyen PT; Nguyen TTH
    Vaccine; 2021 Oct; 39(44):6485-6491. PubMed ID: 34607748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post COVID-19 vaccination: AusVaxSafety survey participation and adverse events - a community-based regional Queensland study.
    Hamilton E; Oversby S; Kitchener S; Ratsch A
    Aust N Z J Public Health; 2022 Dec; 46(6):738-744. PubMed ID: 36190203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events following immunisation of COVID-19 vaccine among health care workers in the first phase of vaccination.
    Rahmat H; Leelavathi M; Wan Ismail WF
    Med J Malaysia; 2022 Nov; 77(6):637-642. PubMed ID: 36448378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Actual Status of Hospitals as COVID-19 Vaccination Clinics in China and Safety Monitoring of Inactivated Vaccine: A Cross-Sectional Study.
    Huang J; Zhang MQ; Huang MZ; Lin GM
    Disaster Med Public Health Prep; 2022 Aug; 17():e256. PubMed ID: 36017705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Repeated Adverse Effects following Booster Dose of mRNA COVID-19 Vaccine: Results from the MOSAICO Study.
    Ferrara P; Ponticelli D; Losa L; Romeo C; Magliuolo R; Vitale A; Zampella A; Alleanza L; Borrelli M; Schiavone B; Mantovani LG
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To Study Adverse Effect following Immunization (AEFI) and COVID-19 Infection amongst COVID-19 Vaccine Benefeciaries.
    N PP; S CS; F JV; B AB; A KM; T DP; N GC; R IA
    J Assoc Physicians India; 2022 Feb; 70(2):11-12. PubMed ID: 35436817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholera and COVID-19 pandemic prevention in multiple hotspot districts of Uganda: vaccine coverage, adverse events following immunization and WASH conditions survey.
    Bwire G; Kisakye A; Amulen E; Bwanika JB; Badebye J; Aanyu C; Nakirya BD; Okello A; Okello SA; Bukenya JN; Orach CG
    BMC Infect Dis; 2023 Jul; 23(1):487. PubMed ID: 37479986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study.
    Zeitoun A; Hallit S; Chehade S; Ibrahim A; Helali M; Allam C; Karam R
    J Pharm Policy Pract; 2023 Feb; 16(1):24. PubMed ID: 36810279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulated Reporting of Adverse Events Following Immunization with COVID-19 Vaccines.
    Jhaj R; Chaudhary D; Shukla AK; Yadav J
    Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.
    Christou-Ergos M; Wiley KE; Leask J
    Vaccine; 2023 Jan; 41(1):246-250. PubMed ID: 36446655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.